These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 26081027)

  • 1. A case of interferon-α-induced pulmonary arterial hypertension after living donor liver transplantation.
    Ko T; Hatano M; Nitta D; Muraoka H; Minatsuki S; Imamura T; Inaba T; Maki H; Yao A; Kinugawa K; Komuro I
    Heart Vessels; 2016 Jul; 31(7):1206-8. PubMed ID: 26081027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible pulmonary arterial hypertension associated with interferon-beta treatment for multiple sclerosis.
    Gibbons E; Promislow S; Davies RA; Chandy G; Stewart DJ; Vladamir CD; Pugliese C; Dunne R; Mielniczuk LM
    Can Respir J; 2015; 22(5):263-5. PubMed ID: 26083539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tadalafil as monotherapy and in combination regimens for the treatment of pulmonary arterial hypertension.
    Udeoji DU; Schwarz ER
    Ther Adv Respir Dis; 2013 Feb; 7(1):39-49. PubMed ID: 23129569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of newly diagnosed sarcoid-associated pulmonary hypertension with ambrisentan and tadalafil combination therapy.
    Abston E; Hon S; Lawrence R; Berman J; Govender P; Farber HW
    Sarcoidosis Vasc Diffuse Lung Dis; 2020; 37(2):234-238. PubMed ID: 33093789
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of Treprostinil on the Early Postoperative Prognosis of Patients with Severe Left Heart Valvular Disease Combined with Severe Pulmonary Hypertension.
    Huang ST; Xu N; Sun KP; Chen Q; Cao H
    Ann Thorac Cardiovasc Surg; 2021 Feb; 27(1):18-24. PubMed ID: 32493870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary arterial hypertension associated with interferon beta treatment for multiple sclerosis: a case report.
    Ledinek AH; Jazbec SS; Drinovec I; Rot U
    Mult Scler; 2009 Jul; 15(7):885-6. PubMed ID: 19465452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognosis and response to first-line single and combination therapy in pulmonary arterial hypertension.
    Kylhammar D; Persson L; Hesselstrand R; Rådegran G
    Scand Cardiovasc J; 2014 Aug; 48(4):223-33. PubMed ID: 24912571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epoprostenol and pulmonary arterial hypertension: 20 years of clinical experience.
    Sitbon O; Vonk Noordegraaf A
    Eur Respir Rev; 2017 Jan; 26(143):. PubMed ID: 28096285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion from sildenafil to tadalafil: results from the sildenafil to tadalafil in pulmonary arterial hypertension (SITAR) study.
    Frantz RP; Durst L; Burger CD; Oudiz RJ; Bourge RC; Franco V; Waxman AB; McDevitt S; Walker S
    J Cardiovasc Pharmacol Ther; 2014 Nov; 19(6):550-7. PubMed ID: 24742768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modern treatment to reduce pulmonary arterial pressure in pulmonary arterial hypertension.
    Akagi S; Matsubara H; Nakamura K; Ito H
    J Cardiol; 2018 Dec; 72(6):466-472. PubMed ID: 29898864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension.
    Voswinckel R; Reichenberger F; Enke B; Kreckel A; Krick S; Gall H; Schermuly RT; Grimminger F; Rubin LJ; Olschewski H; Seeger W; Ghofrani HA
    Pulm Pharmacol Ther; 2008 Oct; 21(5):824-32. PubMed ID: 18657627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Building the case for novel clinical trials in pulmonary arterial hypertension.
    Ryan JJ; Rich JD; Maron BA
    Circ Cardiovasc Qual Outcomes; 2015 Jan; 8(1):114-23. PubMed ID: 25604559
    [No Abstract]   [Full Text] [Related]  

  • 13. Pulmonary hypertension-"state of the art" management in 2012.
    Saxena A
    Indian Heart J; 2012; 64(1):60-73. PubMed ID: 22572428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapies for pulmonary arterial hypertension: where are we today, where do we go tomorrow?
    Seferian A; Simonneau G
    Eur Respir Rev; 2013 Sep; 22(129):217-26. PubMed ID: 23997048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual phosphodiesterase type 5 inhibitor therapy for refractory pulmonary arterial hypertension: a pilot study.
    Kimura M; Tamura Y; Takei M; Yamamoto T; Ono T; Fujita J; Kataoka M; Kuwana M; Satoh T; Fukuda K
    BMC Pulm Med; 2015 May; 15():62. PubMed ID: 25971443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does Portopulmonary Hypertension Impede Liver Transplantation in Cirrhotic Patients? A French Multicentric Retrospective Study.
    Reymond M; Barbier L; Salame E; Besh C; Dumortier J; Pageaux GP; Bureau C; Dharancy S; Vanlemmens C; Abergel A; Woehl Jaegle ML; Magro P; Patat F; Laurent E; Perarnau JM
    Transplantation; 2018 Apr; 102(4):616-622. PubMed ID: 29077657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostanoid therapy for pulmonary arterial hypertension.
    Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
    J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhaled iloprost plus oral sildenafil in patients with severe pulmonary arterial hypertension delays the need for lung transplantation.
    Lopez-Meseguer M; Berastegui C; Monforte V; Bravo C; Domingo E; Roman A
    Transplant Proc; 2013; 45(6):2347-50. PubMed ID: 23953548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended-release oral treprostinil for the treatment of pulmonary arterial hypertension.
    Skoro-Sajer N; Lang I
    Expert Rev Cardiovasc Ther; 2014 Dec; 12(12):1391-9. PubMed ID: 25363827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Marked Reduction of Pulmonary Artery Pressure After Registration for Lung Transplantation Is Associated With Long-Term Survival in Patients With Pulmonary Arterial Hypertension　- Cohort Study.
    Akagi S; Matsubara H; Nakamura K; Oto T; Ejiri K; Ito H
    Circ J; 2020 Jan; 84(2):245-251. PubMed ID: 31866634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.